Orchid Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE191A01027
NSEID: ORCHPHARMA
BSEID: 524372

INR

782.25

-2.1 (-0.27%)

BSENSE

Dec 19

BSE+NSE Vol: 54.14 k

{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "782.25",
    "chg": -2.1,
    "chgp": "-0.27%",
    "dir": -1,
    "prev_price": "784.35",
    "mcapval": "4,004.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE191A01027",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "54.14 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-downgraded-to-strong-sell-by-marketsmojo-amid-weak-fundamentals-3763762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OrchidPharma_mojoScore_3763762.png",
        "date": "2025-12-19 10:10:20",
        "description": "Orchid Pharma has experienced a revision in its evaluation metrics reflecting ongoing operational challenges and market pressures. The pharmaceutical company’s recent assessment highlights shifts across key parameters including quality, valuation, financial trends, and technical outlook, underscoring the complexities faced by this small-cap player in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Orchid Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-orchid-pharma-fallingrising-3761670",
        "imagepath": "",
        "date": "2025-12-18 00:47:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Orchid Pharma’s decline on 17-Dec is part of a broader downward trend. Over the past week, the stock has dropped 3.47%, significantly underperforming the Sensex, which gained 0.20% in the same period. The one-month performance shows a 6.00% fall against a marginal 0.46% decline in the benchmark. More strikingly, the stock has lost over 54% in value year-to-date and over the last twelve months, while the Sensex has gained 8.22% and 4.80% respectively. This stark contrast highlights the company’s struggles amid a generally positive market environment.</p>\n<p>On the day in question, the stock touched an intraday low of ₹805.55, with trading volumes concentrated near this low price, signalling selling pressure. The weighted average pric..."
      },
      {
        "title": "Is Orchid Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-orchid-pharma-technically-bullish-or-bearish-3747693",
        "imagepath": "",
        "date": "2025-12-05 08:29:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 4 December 2025, Orchid Pharma’s technical trend has transitioned from mildly bearish to mildly bullish. This change indicates a tentative improvement in market sentiment, signalling that buyers may be gaining some control after a period of subdued momentum. However, this shift is mild, suggesting that the stock is not yet in a strong uptrend but is showing early signs of recovery.</p>\n<p><strong>Key Technical Indicators: Weekly vs Monthly Perspectives</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), a popular momentum indicator, reveals a divergence between weekly and monthly signals. The weekly MACD is mildly bullish, implying short-term momentum is improving. Conversely, the monthly MACD remains bearish, indicat..."
      },
      {
        "title": "Orchid Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharmas-technical-momentum-shifts-amid-mixed-market-signals-3747726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OrchidPharma_technicaldot_3747726.png",
        "date": "2025-12-05 08:06:50",
        "description": "Orchid Pharma has exhibited a notable shift in its technical momentum, reflecting a nuanced interplay of bullish and bearish signals across key indicators. Recent market data reveals a mild bullish trend on weekly charts contrasting with more cautious monthly signals, underscoring a complex technical landscape for this Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Orchid Pharma Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-forms-golden-cross-indicating-potential-bullish-breakout-3747044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OrchidPharma_goldencross_3747044.png",
        "date": "2025-12-04 18:00:31",
        "description": "Orchid Pharma, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential bullish breakout, suggesting a shift in long-term momentum and a possible trend reversal for the stock."
      },
      {
        "title": "Orchid Pharma’s Evaluation Metrics Revised Amid Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3735202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_mojoScore_3735202.png",
        "date": "2025-11-28 10:05:12",
        "description": "Orchid Pharma has experienced a revision in its evaluation metrics reflecting a more cautious market assessment. This shift follows a series of financial and operational challenges that have influenced the company’s standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Orchid Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-orchid-pharma-technically-bullish-or-bearish-3710247",
        "imagepath": "",
        "date": "2025-11-18 08:30:22",
        "description": "As of 17 November 2025, the technical trend for Orchid Pharma has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the monthly MACD showing a bearish signal. While the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the monthly indicators and the lack of strong signals from the RSI and OBV. The Bollinger Bands present a mixed picture with a bullish weekly stance but a mildly bearish monthly view. Overall, the bearish indicators outweigh the bullish ones, leading to the current mildly bearish assessment...."
      },
      {
        "title": "Orchid Pharma Shows Mixed Technical Signals Amid Market Volatility and Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharmas-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-mixed-performance-3710521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_technicaldot_3710521.png",
        "date": "2025-11-18 08:12:54",
        "description": "Orchid Pharma, a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently priced at 857.95. The stock has experienced a 52-week high of 1,998.00 and a low of 603.80. Its performance over five years shows a substantial return compared to the Sensex, indicating potential resilience."
      },
      {
        "title": "Orchid Pharma Hits Day High with 8.04% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-hits-day-high-with-804-intraday-surge-3707763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OrchidPharma_priceRelatedfactors_3707763.png",
        "date": "2025-11-17 15:01:30",
        "description": "Orchid Pharma's stock has surged today, outperforming its sector and achieving consecutive gains over the past two days. Currently trading above key moving averages, the stock has shown a significant long-term increase despite recent declines. The broader market is also experiencing positive momentum, particularly among mid-cap stocks."
      }
    ],
    "total": 288,
    "sid": "653435",
    "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "17-Nov-2025",
      "details": "Transcript of Analysts/ Investors Earning call held with public at large on November 11 2025 for the quarter ended September 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
      "datetime": "13-Nov-2025",
      "details": "Monitoring Agency Report for the Quarter-2 of F.Y. 2025-26 ended September 30 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "11-Nov-2025",
      "details": "Investor Presentation for the Analysts/Investors Earnings Call for the Q-2 & Half Year for F.Y.2025-26 ended on September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Orchid Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions

2025-12-19 10:10:20

Orchid Pharma has experienced a revision in its evaluation metrics reflecting ongoing operational challenges and market pressures. The pharmaceutical company’s recent assessment highlights shifts across key parameters including quality, valuation, financial trends, and technical outlook, underscoring the complexities faced by this small-cap player in the Pharmaceuticals & Biotechnology sector.

Why is Orchid Pharma falling/rising?

2025-12-18 00:47:17

Recent Price Movement and Market Comparison

Orchid Pharma’s decline on 17-Dec is part of a broader downward trend. Over the past week, the stock has dropped 3.47%, significantly underperforming the Sensex, which gained 0.20% in the same period. The one-month performance shows a 6.00% fall against a marginal 0.46% decline in the benchmark. More strikingly, the stock has lost over 54% in value year-to-date and over the last twelve months, while the Sensex has gained 8.22% and 4.80% respectively. This stark contrast highlights the company’s struggles amid a generally positive market environment.

On the day in question, the stock touched an intraday low of ₹805.55, with trading volumes concentrated near this low price, signalling selling pressure. The weighted average pric...

Is Orchid Pharma technically bullish or bearish?

2025-12-05 08:29:45

Recent Technical Trend Shift

As of 4 December 2025, Orchid Pharma’s technical trend has transitioned from mildly bearish to mildly bullish. This change indicates a tentative improvement in market sentiment, signalling that buyers may be gaining some control after a period of subdued momentum. However, this shift is mild, suggesting that the stock is not yet in a strong uptrend but is showing early signs of recovery.

Key Technical Indicators: Weekly vs Monthly Perspectives

Examining the Moving Average Convergence Divergence (MACD), a popular momentum indicator, reveals a divergence between weekly and monthly signals. The weekly MACD is mildly bullish, implying short-term momentum is improving. Conversely, the monthly MACD remains bearish, indicat...

Orchid Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-05 08:06:50

Orchid Pharma has exhibited a notable shift in its technical momentum, reflecting a nuanced interplay of bullish and bearish signals across key indicators. Recent market data reveals a mild bullish trend on weekly charts contrasting with more cautious monthly signals, underscoring a complex technical landscape for this Pharmaceuticals & Biotechnology stock.

Orchid Pharma Forms Golden Cross, Signalling Potential Bullish Breakout

2025-12-04 18:00:31

Orchid Pharma, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential bullish breakout, suggesting a shift in long-term momentum and a possible trend reversal for the stock.

Orchid Pharma’s Evaluation Metrics Revised Amid Challenging Financial and Market Conditions

2025-11-28 10:05:12

Orchid Pharma has experienced a revision in its evaluation metrics reflecting a more cautious market assessment. This shift follows a series of financial and operational challenges that have influenced the company’s standing within the Pharmaceuticals & Biotechnology sector.

Is Orchid Pharma technically bullish or bearish?

2025-11-18 08:30:22

As of 17 November 2025, the technical trend for Orchid Pharma has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the monthly MACD showing a bearish signal. While the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the monthly indicators and the lack of strong signals from the RSI and OBV. The Bollinger Bands present a mixed picture with a bullish weekly stance but a mildly bearish monthly view. Overall, the bearish indicators outweigh the bullish ones, leading to the current mildly bearish assessment....

Orchid Pharma Shows Mixed Technical Signals Amid Market Volatility and Resilience

2025-11-18 08:12:54

Orchid Pharma, a small-cap pharmaceutical company, has seen significant stock price fluctuations, currently priced at 857.95. The stock has experienced a 52-week high of 1,998.00 and a low of 603.80. Its performance over five years shows a substantial return compared to the Sensex, indicating potential resilience.

Orchid Pharma Hits Day High with 8.04% Intraday Surge

2025-11-17 15:01:30

Orchid Pharma's stock has surged today, outperforming its sector and achieving consecutive gains over the past two days. Currently trading above key moving averages, the stock has shown a significant long-term increase despite recent declines. The broader market is also experiencing positive momentum, particularly among mid-cap stocks.